Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casdatifan drug-drug interaction study with itraconazole and phenytoin
NCT06919991Phase 1Completed
- Sponsor
- Arcus Biosciences
- Start
- May 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of casdatifan, sponsored by Arcus Biosciences. Primary endpoints: Area Under the Plasma Drug Concentration-Time Curve at 120 hours, Maximum Concentration in Plasma at 120 hours and 1 more. Started May 2025; status: completed.
02
Drugs
casdatifan
Beyond the preview
Go deeper on NCT06919991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06919991.